Clinical Trial Update: Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 Fragments

View source ↗

Summary

A completed clinical trial evaluating skin testing with recombinant Bet v 1 and hypoallergenic Bet v 1 fragments in atopic dermatitis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• hypoallergenic recombinant Bet v 1 fragments (hypoallergenic Bet v 1 fragments)
• recombinant Bet v 1 (Bet v 1 allergen)

Snippet

Sponsor: Stefan Woehrl | Conditions: Atopic Dermatitis | Status: COMPLETED